CAPITOL COUNSEL LLC for GENENTECH
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B and Part D coverage of and reimbursement for pharmaceuticals, including oncology, rheumatoid arthritis, ESRD, osteoporosis, diabetes, and access to influenza medications and comparative effectiveness, including related provisions in House and Senate comprehensive health reform legislation, HR 3200 and S.1679, America's Affordable Health Choices Act, and the Senate Finance Committee's America's Healthy Futures Act
Foreign entity interest: Foreign parent company affected by policies that affect Hoffman-La Roche Inc. in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FINLEY | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL New | Communications Dir., Sen. Blanche Lincoln |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.